Skip to content
Search

Latest Stories

RPS launches largest edition of Medicines, Ethics and Practice

RPS launches largest edition of Medicines, Ethics and Practice

The MEP now incorporates guidance from the new RPS Patient Safety Professional standards

The Royal Pharmaceutical Society (RPS) has launched its latest edition of Medicines, Ethics and Practice (MEP), marking it as the largest ever at 258 pages—reflecting a substantial 30 per cent increase in content from the previous edition.

Key updates in this year’s edition include expanded prescribing content, new patient safety standards, a joint position statement by RPS and RCN, and updated information on Valproate Pregnancy Prevention Programme (PPP).


Rakhee Amin, MEP Editor, said: “The MEP continues to support our members and the wider pharmacy profession. The additions of prescribing and patient safety reflect our ongoing commitment to high standards of professional practice.

“We thank everyone who helped build this edition of the MEP, and those who provided expert advice and information during its preparation.”

The MEP now includes detailed signposting to RPS resources and the full text of RPS competency frameworks and guidance, such as the Competency Framework for All Prescribers, the Competency Framework for Designated Prescribing Practitioners, and the Professional Guidance on Expanding Prescribing Scope of Practice.

The latest edition also incorporates guidance from the new RPS Patient Safety Professional standards, designed to support pharmacists in reporting adverse effects and handling dispensing errors more effectively.

These standards have been developed by the RPS, Association of Pharmacy Technicians UK and Pharmacy Forum NI, with the support of an expert steering group and public consultation.

In collaboration with the Royal College of Nursing (RCN), the RPS has added updated information and guidance on the safe practice of prescribing, dispensing, supply, and administration by the same individual.

Additionally, the 47 edition includes updated information on the valproate pregnancy prevention programme, incorporating new legislation and the most recent MHRA guidance on full pack dispensing of valproate-containing medicines.

All Foundation Trainee Members of the RPS will receive a copy of the new MEP free of charge as part of their membership. Copies are available for £52.50 for members and £70 for non-members.

Additionally, all currently practising GB-based pharmacists (excluding Student, Retired, or International Members) can request a free physical copy by completing a quick 4-question form available in the Printed Materials Opt-In section on www.rpharms.com/myRPS.

All RPS members, regardless of their membership type, can access the digital MEP.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less